Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants. Preterm
newborns with PDA are at greater risk for several morbidities, including higher rates of …

The ductus arteriosus (DA) is a fetal shunt vessel that, during prenatal life, diverts blood
away from the pulmonary circulation into the systemic circulation toward the placenta …

Objective To compare the efficacy and safety of oral paracetamol and oral ibuprofen for the
pharmacological closure of patent ductus arteriosus (PDA) in preterm infants. Study design …

Objective: The objective of this study is to evaluate the efficacy and safety of oral
paracetamol versus oral ibuprofen in the treatment of hemodynamically significant patent …

Background: We evaluated the clinical effectiveness of variable courses of paracetamol on
patent ductus arteriosus (PDA) closure and examined its effect on the in vitro term and …

Inhibitors of the cyclo-oxygenase component of prostaglandin-H 2 synthetase, namely
indomethacin and ibuprofen, are commonly used in the treatment of hemodynamically …

Patent ductus arteriosus (PDA) remains a common problem in premature infants. Treatment
options include pharmacologic therapy and surgical ligation, but these are associated with …

Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants which is
inversely related to birth weight and gestational age. Cyclooxygenase inhibitors such as …

Finding the optimal pharmacological treatment of a patent ductus arteriosus (PDA) in
preterm neonates remains challenging. There is a growing interest in paracetamol as a new …

Increasing recent evidence favors paracetamol use for patent ductus arteriosus (PDA)
closure in preterms. Our study aims were (1) to assess efficacy and safety of intravenous (iv) …